Nacuity Pharmaceuticals (Series B)

Funding Details
Awarder
Inbox
Date Award
June 15, 2022
Vertical
Pharmaceuticals
Funding URL
View Funding Page
Funding Amount:
$16,500,000

Company Info
Founders
Halden Conner
Company Description
Nacuity Pharmaceuticals is a pharmaceutical company that aims to develop a breakthrough treatment for retinitis pigmentosa.
Market
Ophthalmology and chronic conditions related to oxidative stress
Location
Fort Worth, Texas, USA

Links